ZFIN Image: Lane et al., 2021, Figure 4

Image

Figure Caption

Figure 4

Loss of CLVS1 causes decreased podocyte endocytosis.

(A–C) Images showing the decreased endocytosis of fluorescently labeled dextran (pHrodo Dextran) in conditionally immortalized podocytes with CRISPR/Cas9-mediated KO of CLVS1 that can be restored with treatment with 1 μM dexamethasone (representative molecules circled in red). (D) Quantification of these images revealed a significant (P = 0.0193) loss of dextran endocytosis in KO podocytes compared with controls that was eliminated when these podocytes were treated with dexamethasone (P = 0.7568, n > 20 for each experimental group, 1-way ANOVA). A selective inhibitor of dynamin I and dynamin II, Dynasore, which reduces clathrin-mediated endocytosis, was used as an endocytosis control. Errors bars depict SEM.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ JCI Insight